Drug Profile
Research Programme: anti-HLA-DR monoclonal antibodies - Kirin Brewery
Alternative Names: HD8 IgG1; Monoclonal anti-HLA-DR antibodyLatest Information Update: 11 Jul 2007
Price :
$50
*
At a glance
- Originator Kirin Brewery
- Developer Kirin Holdings Company
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lymphoma
Most Recent Events
- 20 Apr 2004 Preclinical trials in Lymphoma in Japan (unspecified route)